查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1128734

全球肺癌篩查軟件市場 - 到 2029 年的行業趨勢和預測

Global Lung Cancer Screening Software Market - Industry Trends and Forecast to 2029
出版日期: | 出版商: Data Bridge Market Research | 英文 482 Pages | 商品交期: 請詢問到貨日

價格

預計在 2021-2029 年的預測期內，全球肺癌篩查軟件市場規模的複合年增長率為 19.4%。

全球肺癌病例患病率增加以及對早期診斷和定期篩查益處的認識不斷提高等因素正在推動市場增長。

本報告審視了全球肺癌篩查軟件市場，並提供了市場概況、驅動因素和限制因素、機遇和挑戰、按細分市場和地區劃分的市場細分、競爭格局以及主要參與者的概況。.

內容

第一章介紹

第 2 章市場細分

第 3 章執行摘要

第 4 章重要注意事項

第五章規定及醫療費用

第 6 章市場概述

  • 驅動程序
    • 全球肺癌發病率上升
    • 提高對早期診斷和定期篩查的好處的認識
    • 政府實施各種疾病篩查計劃的努力
    • 全球範圍內越來越多的篩查項目
    • 醫療領域的技術進步
  • 限制因素
    • 軟件可用性問題
    • 缺乏精通技術的癌症診斷專業人員
    • 各個社區缺乏用於癌症和相關疾病的資金和其他資源
  • 機會
    • 擴大市場進入者之間的合作、併購
    • 加大對醫療領域的投資
    • 與肺癌篩查軟件相關的多項好處
  • 任務
    • 篩查軟件和相關服務成本高
    • 與開發肺癌篩查軟件相關的挑戰越來越大
    • 市場競爭加劇

第 7 章全球肺癌篩查軟件市場：按交付方式

  • 概覽
  • 基於雲的解決方案
  • 本地解決方案
  • 基於網絡的解決方案

第 8 章全球肺癌篩查軟件市場：按產品分類

  • 概覽
  • 肺癌篩查放射解決方案
    • 本地解決方案
    • 基於網絡的解決方案
    • 基於雲的解決方案
  • 肺癌篩查患者管理軟件
    • 基於雲的解決方案
    • 本地解決方案
    • 基於網絡的解決方案
  • 結節管理軟件
    • 基於雲的解決方案
    • 本地解決方案
    • 基於網絡的解決方案
  • 數據收集和報告
    • 基於雲的解決方案
    • 基於網絡的解決方案
    • 本地解決方案
  • 患者調整和工作流程
    • 基於雲的解決方案
    • 本地解決方案
    • 基於網絡的解決方案
  • 計算機輔助檢測肺結節
    • 本地解決方案
    • 基於雲的解決方案
    • 基於網絡的解決方案
  • 病理學和癌症分期
    • 基於雲的解決方案
    • 本地解決方案
    • 基於網絡的解決方案
  • 統計審計報告
    • 基於雲的解決方案
    • 本地解決方案
    • 基於網絡的解決方案
  • 篩查圖像存儲通信系統 (PACS)
    • 基於雲的解決方案
    • 本地解決方案
    • 基於網絡的解決方案
  • 診斷管理
    • 基於雲的解決方案
    • 本地解決方案
    • 基於網絡的解決方案
  • 審核日誌跟蹤
    • 基於雲的解決方案
    • 本地解決方案
    • 基於網絡的解決方案

第 9 章全球肺癌篩查軟件市場，按類型分列

  • 概覽
  • 計算機輔助篩查
    • 基於雲的解決方案
    • 本地解決方案
    • 基於網絡的解決方案
  • 常規篩查
    • 基於雲的解決方案
    • 本地解決方案
    • 基於網絡的解決方案

第 10 章全球肺癌篩查軟件市場：按應用分類

  • 概覽
  • 非小細胞肺癌 (NSCLC)
    • 基於雲的解決方案
    • 本地解決方案
    • 基於網絡的解決方案
  • 小細胞肺癌 (SCLC)
    • 基於雲的解決方案
    • 本地解決方案
    • 基於網絡的解決方案

第 11 章全球肺癌篩查軟件市場：按平台劃分

  • 概覽
  • 獨立
    • 基於雲的解決方案
    • 本地解決方案
    • 基於網絡的解決方案
  • 綜合型
    • 基於雲的解決方案
    • 本地解決方案
    • 基於網絡的解決方案

第 12 章全球肺癌篩查軟件市場：按購買方式

  • 概覽
  • 組織
  • 個人

第 13 章全球肺癌篩查軟件市場：按最終用戶分類

  • 概覽
  • 腫瘤中心
  • 醫院
  • 門診手術中心
  • 其他

第 14 章全球肺癌篩查軟件市場：按分銷渠道

  • 概覽
  • 直接出價
  • 第三方分銷商

第 15 章全球肺癌篩查軟件市場：按地區劃分

  • 概覽
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 意大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 瑞士
    • 比利時
    • 土耳其
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 澳大利亞
    • 韓國
    • 印度
    • 新加坡
    • 泰國
    • 馬來西亞
    • 印度尼西亞
    • 菲律賓
    • 其他亞太地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 中東和非洲
    • 南非
    • 南非
    • 阿拉伯聯合酋長國
    • 以色列
    • 埃及
    • 其他中東/非洲

第 16 章全球肺癌篩查軟件市場：公司概況

  • 公司份額分析：全球
  • 公司份額分析：北美
  • 公司份額分析：歐洲
  • 公司份額分析：亞太地區

第 17 章 SWOT 分析

第 18 章公司簡介

  • KONINKLIJKE PHILIPS N.V
  • SIEMENS HEALTHCARE GMBH
  • NUANCE COMMUNICATIONS, INC.
  • GENRAL ELECTRIC (GE HEALTHCARE)
  • ONCOCYTE CORPORATION
  • AIDENCE.COM
  • ASTRAZENECA
  • CANON MEDICAL INFORMATICS, INC.
  • CORELINE SOFT, CO., LTD.
  • EON
  • EPIC SYSTEMS CORPORATION
  • F. HOFFMANN-LA ROCHE LTD
  • FUJIFILM HOLDINGS CORPORATION
  • GENESYSTEM

Global lung cancer screening software market is projected to register a CAGR of 19.4% in the forecast period of 2021 to 2029. The new market report contains data for historic year 2020, the base year of calculation is 2021 and the forecast period is 2021 to 2029.

Market Segmentation

Global Lung Cancer Screening Software Market, By Mode of Delivery (Cloud Based Solutions, On-Premise Solutions, and Web Based Solutions), Product (Lung Cancer Screening Radiology Solution, Lung Cancer Screening Patient Management Software, Nodule Management Software, Data Collection and Reporting, Patient Coordination and Workflow, Lung Nodule Computer Aided Detection, Pathology and Cancer Staging, Statistical Audit Reporting, Screening PACS, Practice Management, and Audit Log Tracking), Type (Computer-Assisted Screening and Traditional Screening), Application (Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC)), Platform (Standalone and Integrated), Purchase Mode (Institutional and Individual), End User (Oncology Centers, Hospitals, Ambulatory Surgical Centers, and Others), Distribution Channel (Direct Tender and Third Party Distributors), Country (U.S., Canada, Mexico, U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Belgium, Turkey, Rest of Europe, China, Japan, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America) Industry Trends and Forecast to 2029.

Some of the major factors contributing to the growth of the global lung cancer screening software market are:

Increasing prevalence of lung cancer cases globally

Increasing awareness regarding the benefits of early diagnosis and frequent screening

Market Players

The key market players for the global lung cancer screening software market are listed below:

Koninklijke Philiphs N.V

Siemens Healthcare GmbH

Nuance Communication, Inc.

General Electric Company

Oncocyte Corporation

Aidence.com

AstraZeneca

Canon Medical Informatics, Inc.

Coreline Soft, Co., Ltd.

Eon

Epic Systems Corporation

F. Hoffmann-La Roche Ltd

FUJIFILM Holdings Corporation

Genesystem

HealthMyne

Lungview

MagView

Median Technologies

Medtronic

MeVis Medical Solutions AG

MyCareWare Inc.

Optellum Ltd

PenRad Technologies Inc.

REVEALDX

Thynk Health

Volpara Health Limited

TABLE OF CONTENTS

1 INTRODUCTION 62

  • 1.1 OBJECTIVES OF THE STUDY 62
  • 1.2 MARKET DEFINITION 62
  • 1.3 OVERVIEW OF GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET 62
  • 1.4 LIMITATION 64
  • 1.5 MARKETS COVERED 65

2 MARKET SEGMENTATION 68

  • 2.1 MARKETS COVERED 68
  • 2.2 GEOGRAPHICAL SCOPE 69
  • 2.3 YEARS CONSIDERED FOR THE STUDY 70
  • 2.4 CURRENCY AND PRICING 70
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL 71
  • 2.6 MULTIVARIATE MODELLING 74
  • 2.7 PRODUCT LIFELINE CURVE 74
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 75
  • 2.9 DBMR MARKET POSITION GRID 76
  • 2.10 VENDOR SHARE ANALYSIS 78
  • 2.11 SECONDARY SOURCES 79
  • 2.12 ASSUMPTIONS 79

3 EXECUTIVE SUMMARY 80

4 PREMIUM INSIGHTS 84

5 REGULATIONS & REIMBURSEMENT 86

6 MARKET OVERVIEW 87

  • 6.1 DRIVERS 89
    • 6.1.1 INCREASE IN PREVALENCE OF LUNG CANCER CASES GLOBALLY 89
    • 6.1.2 INCREASE IN AWARENESS REGARDING THE BENEFITS OF EARLY DIAGNOSIS AND FREQUENT SCREENING 89
    • 6.1.3 GOVERNMENT INITIATIVES WERE UNDERTAKEN TO IMPLEMENT SCREENING PROGRAMS FOR VARIOUS DISEASES 90
    • 6.1.4 GROWING NUMBER OF SCREENING PROGRAMS ACROSS THE GLOBE 90
    • 6.1.5 TECHNOLOGICAL ADVANCEMENTS IN THE FIELD OF HEALTHCARE 91
  • 6.2 RESTRAINTS 92
    • 6.2.1 ISSUES RELATED TO THE AVAILABILITY OF SOFTWARE 92
    • 6.2.2 SCARCITY OF TECHNICALLY KNOWLEDGEABLE PROFESSIONALS FOR CANCER DIAGNOSIS 92
    • 6.2.3 LACK OF FUNDING AND OTHER RESOURCES FROM VARIOUS REGIONS FOR CANCER AND ASSOCIATED DISORDERS 92
  • 6.3 OPPORTUNITIES 93
    • 6.3.1 RISING COLLABORATIONS, MERGERS & ACQUISITIONS AMONG THE MARKET PLAYERS 93
    • 6.3.2 INCREASING INVESTMENTS IN HEALTHCARE SEGMENTS 94
    • 6.3.3 MULTIPLE BENEFITS ASSOCIATED WITH LUNG CANCER SCREENING SOFTWARE 94
  • 6.4 CHALLENGES 95
    • 6.4.1 HIGH COST OF SCREENING SOFTWARE AND RELATED SERVICES 95
    • 6.4.2 INCREASING CHALLENGES RELATED TO THE DEVELOPMENT OF LUNG CANCER SCREENING SOFTWARE 95
    • 6.4.3 INCREASING COMPETITION IN THE MARKET 96

7 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY 97

  • 7.1 OVERVIEW 98
  • 7.2 CLOUD BASED SOLUTIONS 99
  • 7.3 ON-PREMISE SOLUTIONS 100
  • 7.4 WEB BASED SOLUTIONS 100

8 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT 102

  • 8.1 OVERVIEW 103
  • 8.2 LUNG CANCER SCREENING RADIOLOGY SOLUTION 105
    • 8.2.1 ON-PREMISE SOLUTIONS 105
    • 8.2.2 WEB BASED SOLUTIONS 106
    • 8.2.3 CLOUD BASED SOLUTIONS 106
  • 8.3 LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE 106
    • 8.3.1 CLOUD BASED SOLUTIONS 107
    • 8.3.2 ON-PREMISE SOLUTIONS 107
    • 8.3.3 WEB BASED SOLUTIONS 107
  • 8.4 NODULE MANAGEMENT SOFTWARE 107
    • 8.4.1 CLOUD BASED SOLUTIONS 108
    • 8.4.2 ON-PREMISE SOLUTIONS 108
    • 8.4.3 WEB BASED SOLUTIONS 108
  • 8.5 DATA COLLECTION AND REPORTING 109
    • 8.5.1 CLOUD BASED SOLUTIONS 110
    • 8.5.2 WEB BASED SOLUTIONS 110
    • 8.5.3 ON-PREMISE SOLUTIONS 110
  • 8.6 PATIENT COORDINATION AND WORKFLOW 110
    • 8.6.1 CLOUD BASED SOLUTIONS 111
    • 8.6.2 ON-PREMISE SOLUTIONS 111
    • 8.6.3 WEB BASED SOLUTIONS 111
  • 8.7 LUNG NODULE COMPUTER AIDED DETECTION 111
    • 8.7.1 ON-PREMISE SOLUTIONS 112
    • 8.7.2 CLOUD BASED SOLUTIONS 112
    • 8.7.3 WEB BASED SOLUTIONS 112
  • 8.8 PATHOLOGY AND CANCER STAGING 113
    • 8.8.1 CLOUD BASED SOLUTIONS 114
    • 8.8.2 ON-PREMISE SOLUTIONS 114
    • 8.8.3 WEB BASED SOLUTIONS 114
  • 8.9 STATISTICAL AUDIT REPORTING 114
    • 8.9.1 CLOUD BASED SOLUTIONS 115
    • 8.9.2 ON-PREMISE SOLUTIONS 115
    • 8.9.3 WEB BASED SOLUTIONS 115
  • 8.10 SCREENING PACS 115
    • 8.10.1 CLOUD BASED SOLUTIONS 116
    • 8.10.2 ON-PREMISE SOLUTIONS 116
    • 8.10.3 WEB BASED SOLUTIONS 116
  • 8.11 PRACTICE MANAGEMENT 116
    • 8.11.1 CLOUD BASED SOLUTIONS 117
    • 8.11.2 ON-PREMISE SOLUTIONS 118
    • 8.11.3 WEB BASED SOLUTIONS 118
  • 8.12 AUDIT LOG TRACKING 118
    • 8.12.1 CLOUD BASED SOLUTIONS 119
    • 8.12.2 ON-PREMISE SOLUTIONS 119
    • 8.12.3 WEB BASED SOLUTIONS 119

9 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE 120

  • 9.1 OVERVIEW 121
  • 9.2 COMPUTER-ASSISTED SCREENING 122
    • 9.2.1 CLOUD BASED SOLUTIONS 123
    • 9.2.2 ON-PREMISE SOLUTIONS 123
    • 9.2.3 WEB BASED SOLUTIONS 123
  • 9.3 TRADITIONAL SCREENING 123
    • 9.3.1 CLOUD BASED SOLUTIONS 124
    • 9.3.2 ON-PREMISE SOLUTIONS 124
    • 9.3.3 WEB BASED SOLUTIONS 124

10 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION 125

  • 10.1 OVERVIEW 126
  • 10.2 NON-SMALL CELL LUNG CANCER (NSCLC) 127
    • 10.2.1 CLOUD BASED SOLUTIONS 128
    • 10.2.2 ON-PREMISE SOLUTIONS 128
    • 10.2.3 WEB BASED SOLUTIONS 128
  • 10.3 SMALL CELL LUNG CANCER (SCLC) 128
    • 10.3.1 CLOUD BASED SOLUTIONS 129
    • 10.3.2 ON-PREMISE SOLUTIONS 129
    • 10.3.3 WEB BASED SOLUTIONS 129

11 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM 130

  • 11.1 OVERVIEW 131
  • 11.2 STANDALONE 132
    • 11.2.1 CLOUD BASED SOLUTIONS 133
    • 11.2.2 ON-PREMISE SOLUTIONS 133
    • 11.2.3 WEB BASED SOLUTIONS 133
  • 11.3 INTEGRATED 133
    • 11.3.1 CLOUD BASED SOLUTIONS 134
    • 11.3.2 ON-PREMISE SOLUTIONS 134
    • 11.3.3 WEB BASED SOLUTIONS 134

12 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET, BY PURCHASE MODE 135

  • 12.1 OVERVIEW 136
  • 12.2 INSTITUTIONAL 137
  • 12.3 INDIVIDUAL 138

13 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET, BY END USER 139

  • 13.1 OVERVIEW 140
  • 13.2 ONCOLOGY CENTERS 141
  • 13.3 HOSPITALS 142
  • 13.4 AMBULATORY SURGICAL CENTERS 142
  • 13.5 OTHERS 143

14 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET, BY DISTRIBUTION CHANNEL 144

  • 14.1 OVERVIEW 145
  • 14.2 DIRECT TENDERS 146
  • 14.3 THIRD PARTY DISTRIBUTOR 147

15 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION 148

  • 15.1 OVERVIEW 149
  • 15.2 NORTH AMERICA 155
    • 15.2.1 U.S. 166
    • 15.2.2 CANADA 173
    • 15.2.3 MEXICO 180
  • 15.3 EUROPE 187
    • 15.3.1 GERMANY 199
    • 15.3.2 FRANCE 206
    • 15.3.3 U.K. 213
    • 15.3.4 ITALY 220
    • 15.3.5 SPAIN 227
    • 15.3.6 NETHERLANDS 234
    • 15.3.7 RUSSIA 241
    • 15.3.8 SWITZERLAND 248
    • 15.3.9 BELGIUM 255
    • 15.3.10 TURKEY 262
    • 15.3.11 REST OF EUROPE 269
  • 15.4 ASIA-PACIFIC 270
    • 15.4.1 JAPAN 282
    • 15.4.2 CHINA 289
    • 15.4.3 AUSTRALIA 296
    • 15.4.4 SOUTH KOREA 304
    • 15.4.5 INDIA 312
    • 15.4.6 SINGAPORE 320
    • 15.4.7 THAILAND 327
    • 15.4.8 MALAYSIA 334
    • 15.4.9 INDONESIA 341
    • 15.4.10 PHILIPPINES 348
    • 15.4.11 REST OF ASIA-PACIFIC 355
  • 15.5 SOUTH AMERICA 356
    • 15.5.1 BRAZIL 367
    • 15.5.2 ARGENTINA 374
    • 15.5.3 REST OF SOUTH AMERICA 381
  • 15.6 MIDDLE EAST & AFRICA 382
    • 15.6.1 SOUTH AFRICA 394
    • 15.6.2 SOUTH AFRICA 401
    • 15.6.3 U.A.E 408
    • 15.6.4 ISRAEL 415
    • 15.6.5 EGYPT 422
    • 15.6.6 REST OF MIDDLE EAST AND AFRICA 429

16 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET: COMPANY LANDSCAPE 430

  • 16.1 COMPANY SHARE ANALYSIS: GLOBAL 430
  • 16.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 431
  • 16.3 COMPANY SHARE ANALYSIS: EUROPE 432
  • 16.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 433

17 SWOT ANALYSIS 434

18 COMPANY PROFILE 435

  • 18.1 KONINKLIJKE PHILIPS N.V 435
    • 18.1.1 COMPANY SNAPSHOT 435
    • 18.1.2 REVENUE ANALYSIS 435
    • 18.1.3 COMPANY SHARE ANALYSIS 436
    • 18.1.4 PRODUCT PORTFOLIO 436
    • 18.1.5 RECENT DEVELOPMENTS 436
  • 18.2 SIEMENS HEALTHCARE GMBH 438
    • 18.2.1 COMPANY SNAPSHOT 438
    • 18.2.2 REVENUE ANALYSIS 438
    • 18.2.3 COMPANY SHARE ANALYSIS 439
    • 18.2.4 PRODUCT PORTFOLIO 439
    • 18.2.5 RECENT DEVELOPMENTS 439
  • 18.3 NUANCE COMMUNICATIONS, INC. 441
    • 18.3.1 COMPANY SNAPSHOT 441
    • 18.3.2 REVENUE ANALYSIS 441
    • 18.3.3 COMPANY SHARE ANALYSIS 442
    • 18.3.4 PRODUCT PORTFOLIO 442
    • 18.3.5 RECENT DEVELOPMENTS 442
  • 18.4 GENRAL ELECTRIC (GE HEALTHCARE) 444
    • 18.4.1 COMPANY SNAPSHOT 444
    • 18.4.2 COMPANY SHARE ANALYSIS 444
    • 18.4.3 PRODUCT PORTFOLIO 445
    • 18.4.4 RECENT DEVELOPMENTS 445
  • 18.5 ONCOCYTE CORPORATION 446
    • 18.5.1 COMPANY SNAPSHOT 446
    • 18.5.2 REVENUE ANALYSIS 446
    • 18.5.3 COMPANY SHARE ANALYSIS 447
    • 18.5.4 PRODUCT PORTFOLIO 447
    • 18.5.5 RECENT DEVELOPMENT 447
  • 18.6 AIDENCE.COM 448
    • 18.6.1 COMPANY SNAPSHOT 448
    • 18.6.3 PRODUCT PORTFOLIO 448
    • 18.6.4 RECENT DEVELOPMENT 448
  • 18.7 ASTRAZENECA 449
    • 18.7.1 COMPANY SNAPSHOT 449
    • 18.7.2 REVENUE ANALYSIS 449
    • 18.7.3 PRODUCT PORTFOLIO 450
    • 18.7.4 RECENT DEVELOPMENT 450
  • 18.8 CANON MEDICAL INFORMATICS, INC. 451
    • 18.8.1 COMPANY SNAPSHOT 451
    • 18.8.2 PRODUCT PORTFOLIO 451
    • 18.8.3 RECENT DEVELOPMENTS 451
  • 18.9 CORELINE SOFT, CO., LTD. 452
    • 18.9.1 COMPANY SNAPSHOT 452
    • 18.9.2 PRODUCT PORTFOLIO 452
    • 18.9.3 RECENT DEVELOPMENTS 452
  • 18.10 EON 454
    • 18.10.1 COMPANY SNAPSHOT 454
    • 18.10.2 PRODUCT PORTFOLIO 454
    • 18.10.3 RECENT DEVELOPMENT 454
  • 18.11 EPIC SYSTEMS CORPORATION 455
    • 18.11.1 COMPANY SNAPSHOT 455
    • 18.11.2 PRODUCT PORTFOLIO 455
    • 18.11.3 RECENT DEVELOPMENT 455
  • 18.12 F. HOFFMANN-LA ROCHE LTD 456
    • 18.12.1 COMPANY SNAPSHOT 456
    • 18.12.2 REVENUE ANALYSIS 456
    • 18.12.3 PRODUCT PORTFOLIO 457
    • 18.12.4 RECENT DEVELOPMENTS 457
  • 18.13 FUJIFILM HOLDINGS CORPORATION 458
    • 18.13.1 COMPANY SNAPSHOT 458
    • 18.13.2 REVENUE ANALYSIS 458
    • 18.13.3 PRODUCT PORTFOLIO 459
    • 18.13.4 RECENT DEVELOPMENTS 459
  • 18.14 GENESYSTEM 460
    • 18.14.1 COMPANY SNAPSHOT 460
    • 18.14.2 PRODUCT PORTFOLIO 460
    • 18.14.3 RECENT DEVELOPMENT 460
  • 18.15 HEALTHMYNE 461
    • 18.15.1 COMPANY SNAPSHOT 461
    • 18.15.2 PRODUCT PORTFOLIO 461
    • 18.15.3 RECENT DEVELOPMENTS 462
  • 18.16 LUNGVIEW 463
    • 18.16.1 COMPANY SNAPSHOT 463
    • 18.16.2 PRODUCT PORTFOLIO 463
    • 18.16.3 RECENT DEVELOPMENT 463
  • 18.17 MAGVIEW 464
    • 18.17.1 COMPANY SNAPSHOT 464
    • 18.17.2 PRODUCT PORTFOLIO 464
    • 18.17.3 RECENT DEVELOPMENT 464
  • 18.18 MEDIAN TECHNOLOGIES 465
    • 18.18.1 COMPANY SNAPSHOT 465
    • 18.18.2 REVENUE ANALYSIS 465
    • 18.18.3 PRODUCT PORTFOLIO 466
    • 18.18.4 RECENT DEVELOPMENT 466
  • 18.19 MEDTRONIC 467
    • 18.19.1 COMPANY SNAPSHOT 467
    • 18.19.2 REVENUE ANALYSIS 467
    • 18.19.3 PRODUCT PORTFOLIO 468
    • 18.19.4 RECENT DEVELOPMENTS 468
  • 18.20 MEVIS MEDICAL SOLUTIONS AG 469
    • 18.20.1 COMPANY SNAPSHOT 469
    • 18.20.2 REVENUE ANALYSIS 469
    • 18.20.3 PRODUCT PORTFOLIO 470
    • 18.20.4 RECENT DEVELOPMENT 470
  • 18.21 MYCAREWARE INC. 471
    • 18.21.1 COMPANY SNAPSHOT 471
    • 18.21.2 PRODUCT PORTFOLIO 471
    • 18.21.3 RECENT DEVELOPMENT 471
  • 18.22 OPTELLUM LTD 472
    • 18.22.1 COMPANY SNAPSHOT 472
    • 18.22.2 PRODUCT PORTFOLIO 472
    • 18.22.3 RECENT DEVELOPMENTS 472
  • 18.23 PENRAD TECHNOLOGIES INC. 474
    • 18.23.1 COMPANY SNAPSHOT 474
    • 18.23.2 PRODUCT PORTFOLIO 474
    • 18.23.3 RECENT DEVELOPMENT 474
  • 18.24 REVEALDX 475
    • 18.24.1 COMPANY SNAPSHOT 475
    • 18.24.2 PRODUCT PORTFOLIO 475
    • 18.24.3 RECENT DEVELOPMENT 475
  • 18.25 THYNK HEALTH 476
    • 18.25.1 COMPANY SNAPSHOT 476
    • 18.25.2 PRODUCT PORTFOLIO 476
    • 18.25.3 RECENT DEVELOPMENT 476
  • 18.26 VOLPARA SOLUTIONS LIMITED 477
    • 18.26.1 COMPANY SNAPSHOT 477
    • 18.26.2 REVENUE ANALYSIS 477
    • 18.26.3 PRODUCT PORTFOLIO 478
    • 18.26.4 RECENT DEVELOPMENTS 478

19 QUESTIONNAIRE 479

20 RELATED REPORTS 482

LIST OF TABLES

  • TABLE 1 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY, 2020-2029 (USD THOUSAND) 99
  • TABLE 2 GLOBAL CLOUD BASED SOLUTIONS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND) 99
  • TABLE 3 GLOBAL ON-PREMISE SOLUTIONS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND) 100
  • TABLE 4 GLOBAL WEB BASED SOLUTIONS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND) 101
  • TABLE 5 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 104
  • TABLE 6 GLOBAL LUNG CANCER SCREENING RADIOLOGY SOLUTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND) 105
  • TABLE 7 GLOBAL LUNG CANCER SCREENING RADIOLOGY SOLUTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND) 105
  • TABLE 8 GLOBAL LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND) 106
  • TABLE 9 GLOBAL LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND) 107
  • TABLE 10 GLOBAL NODULE MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND) 108
  • TABLE 11 GLOBAL NODULE MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND) 108
  • TABLE 12 GLOBAL DATA COLLECTION AND REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND) 109
  • TABLE 13 GLOBAL DATA COLLECTION AND REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND) 109
  • TABLE 14 GLOBAL PATIENT COORDINATION AND WORKFLOW IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND) 110
  • TABLE 15 GLOBAL PATIENT COORDINATION AND WORKFLOW IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND) 111
  • TABLE 16 GLOBAL LUNG NODULE COMPUTER AIDED DETECTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND) 112
  • TABLE 17 GLOBAL LUNG NODULE COMPUTER AIDED DETECTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND) 112
  • TABLE 18 GLOBAL PATHOLOGY AND CANCER STAGING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND) 113
  • TABLE 19 GLOBAL PATHOLOGY AND CANCER STAGING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND) 113
  • TABLE 20 GLOBAL STATISTICAL AUDIT REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND) 114
  • TABLE 21 GLOBAL STATISTICAL AUDIT REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND) 115
  • TABLE 22 GLOBAL SCREENING PACS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND) 116
  • TABLE 23 GLOBAL SCREENING PACS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND) 116
  • TABLE 24 GLOBAL PRACTICE MANAGEMENT IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND) 117
  • TABLE 25 GLOBAL PRACTICE MANAGEMENT IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND) 117
  • TABLE 26 GLOBAL AUDIT LOG TRACKING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND) 118
  • TABLE 27 GLOBAL AUDIT LOG TRACKING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND) 119
  • TABLE 28 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND) 122
  • TABLE 29 GLOBAL COMPUTER-ASSISTED SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND) 122
  • TABLE 30 GLOBAL COMPUTER-ASSISTED SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND) 123
  • TABLE 31 GLOBAL TRADITIONAL SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND) 124
  • TABLE 32 GLOBAL TRADITIONAL SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND) 124
  • TABLE 33 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND) 127
  • TABLE 34 GLOBAL NON-SMALL CELL LUNG CANCER (NSCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND) 127
  • TABLE 35 GLOBAL NON-SMALL CELL LUNG CANCER (NSCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND) 128
  • TABLE 36 GLOBAL SMALL CELL LUNG CANCER (SCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND) 129
  • TABLE 37 GLOBAL SMALL CELL LUNG CANCER (SCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND) 129
  • TABLE 38 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND) 132
  • TABLE 39 GLOBAL STANDALONE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND) 132
  • TABLE 40 GLOBAL STANDALONE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND) 133
  • TABLE 41 GLOBAL INTEGRATED IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND) 134
  • TABLE 42 GLOBAL INTEGRATED IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND) 134
  • TABLE 43 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET, BY PURCHASE MODE, 2020-2029 (USD THOUSAND) 137
  • TABLE 44 GLOBAL INSTITUTIONAL IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND) 137
  • TABLE 45 GLOBAL INDIVIDUAL IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND) 138
  • TABLE 46 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET, BY END USER, 2020-2029 (USD THOUSAND) 141
  • TABLE 47 GLOBAL ONCOLOGY CENTERS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND) 141
  • TABLE 48 GLOBAL HOSPITALS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND) 142
  • TABLE 49 GLOBAL AMBULATORY SURGICAL CENTERS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND) 143
  • TABLE 50 GLOBAL OTHERS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND) 143
  • TABLE 51 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND) 146
  • TABLE 52 GLOBAL DIRECT TENDERS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND) 146
  • TABLE 53 GLOBAL THIRD PARTY DISTRIBUTOR IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND) 147
  • TABLE 54 GLOBAL LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD MILLION) 154
  • TABLE 55 NORTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET, BY COUNTRY, 2020-2029 (USD THOUSAND) 159
  • TABLE 56 NORTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY, 2020-2029 (USD THOUSAND) 159
  • TABLE 57 NORTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 159
  • TABLE 58 NORTH AMERICA LUNG CANCER SCREENING RADIOLOGY SOLUTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 160
  • TABLE 59 NORTH AMERICA LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 160
  • TABLE 60 NORTH AMERICA NODULE MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 160
  • TABLE 61 NORTH AMERICA DATA COLLECTION AND REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 160
  • TABLE 62 NORTH AMERICA PATIENT COORDINATION AND WORKFLOW IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 161
  • TABLE 63 NORTH AMERICA LUNG NODULE COMPUTER AIDED DETECTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 161
  • TABLE 64 NORTH AMERICA PATHOLOGY AND CANCER STAGING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 161
  • TABLE 65 NORTH AMERICA STATISTICAL AUDIT REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 161
  • TABLE 66 NORTH AMERICA SCREENING PACS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 162
  • TABLE 67 NORTH AMERICA PRACTICE MANAGEMENT IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 162
  • TABLE 68 NORTH AMERICA AUDIT LOG TRACKING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 162
  • TABLE 69 NORTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND) 162
  • TABLE 70 NORTH AMERICA COMPUTER-ASSISTED SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND) 163
  • TABLE 71 NORTH AMERICA TRADITIONAL SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND) 163
  • TABLE 72 NORTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND) 163
  • TABLE 73 NORTH AMERICA NON-SMALL CELL LUNG CANCER (NSCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT TYPE, 2020-2029 (USD THOUSAND) 163
  • TABLE 74 NORTH AMERICA SMALL CELL LUNG CANCER (SCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND) 164
  • TABLE 75 NORTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND) 164
  • TABLE 76 NORTH AMERICA STANDALONE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND) 164
  • TABLE 77 NORTH AMERICA INTEGRATED IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND) 164
  • TABLE 78 NORTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET, BY PURCHASE MODE, 2020-2029 (USD THOUSAND) 165
  • TABLE 79 NORTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET, BY END USER, 2020-2029 (USD THOUSAND) 165
  • TABLE 80 NORTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND) 165
  • TABLE 81 U.S. LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY, 2020-2029 (USD THOUSAND) 166
  • TABLE 82 U.S. LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 166
  • TABLE 83 U.S. LUNG CANCER SCREENING RADIOLOGY SOLUTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 167
  • TABLE 84 U.S. LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 167
  • TABLE 85 U.S. NODULE MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 167
  • TABLE 86 U.S. DATA COLLECTION AND REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 167
  • TABLE 87 U.S. PATIENT COORDINATION AND WORKFLOW IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 168
  • TABLE 88 U.S. LUNG NODULE COMPUTER AIDED DETECTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 168
  • TABLE 89 U.S. PATHOLOGY AND CANCER STAGING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 168
  • TABLE 90 U.S. STATISTICAL AUDIT REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 168
  • TABLE 91 U.S. SCREENING PACS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 169
  • TABLE 92 U.S. PRACTICE MANAGEMENT IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 169
  • TABLE 93 U.S. AUDIT LOG TRACKING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 169
  • TABLE 94 U.S. LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND) 169
  • TABLE 95 U.S. COMPUTER-ASSISTED SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND) 170
  • TABLE 96 U.S. TRADITIONAL SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND) 170
  • TABLE 97 U.S. LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND) 170
  • TABLE 98 U.S. NON-SMALL CELL LUNG CANCER (NSCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT TYPE, 2020-2029 (USD THOUSAND) 170
  • TABLE 99 U.S. SMALL CELL LUNG CANCER (SCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND) 171
  • TABLE 100 U.S. LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND) 171
  • TABLE 101 U.S. STANDALONE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND) 171
  • TABLE 102 U.S. INTEGRATED IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND) 171
  • TABLE 103 U.S. LUNG CANCER SCREENING SOFTWARE MARKET, BY PURCHASE MODE, 2020-2029 (USD THOUSAND) 172
  • TABLE 104 U.S. LUNG CANCER SCREENING SOFTWARE MARKET, BY END USER, 2020-2029 (USD THOUSAND) 172
  • TABLE 105 U.S. LUNG CANCER SCREENING SOFTWARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND) 172
  • TABLE 106 CANADA LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY, 2020-2029 (USD THOUSAND) 173
  • TABLE 107 CANADA LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 173
  • TABLE 108 CANADA LUNG CANCER SCREENING RADIOLOGY SOLUTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 174
  • TABLE 109 CANADA LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 174
  • TABLE 110 CANADA NODULE MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 174
  • TABLE 111 CANADA DATA COLLECTION AND REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 174
  • TABLE 112 CANADA PATIENT COORDINATION AND WORKFLOW IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 175
  • TABLE 113 CANADA LUNG NODULE COMPUTER AIDED DETECTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 175
  • TABLE 114 CANADA PATHOLOGY AND CANCER STAGING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 175
  • TABLE 115 CANADA STATISTICAL AUDIT REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 175
  • TABLE 116 CANADA SCREENING PACS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 176
  • TABLE 117 CANADA PRACTICE MANAGEMENT IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 176
  • TABLE 118 CANADA AUDIT LOG TRACKING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 176
  • TABLE 119 CANADA LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND) 176
  • TABLE 120 CANADA COMPUTER-ASSISTED SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND) 177
  • TABLE 121 CANADA TRADITIONAL SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND) 177
  • TABLE 122 CANADA LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND) 177
  • TABLE 123 CANADA NON-SMALL CELL LUNG CANCER (NSCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT TYPE, 2020-2029 (USD THOUSAND) 177
  • TABLE 124 CANADA SMALL CELL LUNG CANCER (SCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND) 178
  • TABLE 125 CANADA LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND) 178
  • TABLE 126 CANADA STANDALONE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND) 178
  • TABLE 127 CANADA INTEGRATED IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND) 178
  • TABLE 128 CANADA LUNG CANCER SCREENING SOFTWARE MARKET, BY PURCHASE MODE, 2020-2029 (USD THOUSAND) 179
  • TABLE 129 CANADA LUNG CANCER SCREENING SOFTWARE MARKET, BY END USER, 2020-2029 (USD THOUSAND) 179
  • TABLE 130 CANADA LUNG CANCER SCREENING SOFTWARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND) 179
  • TABLE 131 MEXICO LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY, 2020-2029 (USD THOUSAND) 180
  • TABLE 132 MEXICO LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 180
  • TABLE 133 MEXICO LUNG CANCER SCREENING RADIOLOGY SOLUTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 181
  • TABLE 134 MEXICO LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 181
  • TABLE 135 MEXICO NODULE MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 181
  • TABLE 136 MEXICO DATA COLLECTION AND REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 181
  • TABLE 137 MEXICO PATIENT COORDINATION AND WORKFLOW IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 182
  • TABLE 138 MEXICO LUNG NODULE COMPUTER AIDED DETECTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 182
  • TABLE 139 MEXICO PATHOLOGY AND CANCER STAGING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 182
  • TABLE 140 MEXICO STATISTICAL AUDIT REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 182
  • TABLE 141 MEXICO SCREENING PACS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 183
  • TABLE 142 MEXICO PRACTICE MANAGEMENT IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 183
  • TABLE 143 MEXICO AUDIT LOG TRACKING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND) 183
  • TABLE 144 MEXICO LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND) 183
  • TABLE 145 MEXICO COMPUTER-ASSISTED SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND) 184
  • TABLE 146 MEXICO TRADITIONAL SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND) 184
  • TABLE 147 MEXICO LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND) 184
  • TABLE 148 MEXICO NON-SMALL CELL LUNG CANCER (NSCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT TYPE, 2020-2029 (USD THOUSAND) 184